Home › NDC Lookup › Ingredients › Glycerin 6%,Lidocaine 4%,Ectoin 0.12% › 85524-2602-02
Hemorrhoid and Fissure Glycerin 6%,Lidocaine 4%,Ectoin 0.12% .0012 g/g; .04 g/g; .06 g/g Ointment, 1 bottle — NDC 85524-2602-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Hemorrhoid and Fissure Glycerin 6%,Lidocaine 4%,Ectoin 0.12% .0012 g/g; .04 g/g; .06 g/g Ointment, 1 bottle — NDC 85524-2602-2 (Billing 85524-2602-02)

by FlexiGo Inc · 1 BOTTLE in 1 BOX / 42.5 g in 1 BOTTLE

This is a package of 1 bottle of Hemorrhoid and Fissure Glycerin 6%,Lidocaine 4%,Ectoin 0.12% .0012 g/g; .04 g/g; .06 g/g Ointment from FlexiGo Inc, marketed since Jan 2026 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 85524-2602-02
🏷️ FDA NDC (as labeled) 85524-2602-2 billing pads the package segment with a zero
This package
Contains1 bottle Pack sizes3 compare ↓
Main listing for product 85524-2602 · Also comes in: 42.5 g 85524-2602-4 42.5 g 85524-2602-6
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 85524-2602-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
85524 labeler · 2602 product · 2 package
Package marketed since
Jan 19, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8552426022 3
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 85524-2602-2
Product NDC 85524-2602
11-digit billing NDC 85524260202
UNII 7GXZ3858RY, 98PI200987, PDC6A3C0OX
Application # M015
SPL Set ID 48697377-61c0-1b0a-e063-6294a90a3293
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic; Non-Standardized Chemical Allergen
Physiologic effect Local Anesthesia; Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Amides; Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-01-19
Route TOPICAL
Dosage form OINTMENT
Substance ECTOIN; LIDOCAINE; GLYCERIN
Why two NDCs? The FDA registers this code as 85524-2602-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 85524-2602-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an over-the-counter topical ointment marketed under FDA's monograph rules for hemorrhoid and fissure care. It contains three active ingredients: lidocaine, a local anesthetic typically used to numb pain and itching in the area where it is applied; glycerin, a moisturizing agent commonly used to soften and soothe irritated skin; and ectoin, a protective substance often found in products intended to help support skin barrier function. The ointment is applied directly to the affected area.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 42.5 g 42.5 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
85524-2602-02 You're viewing this Main listing 1 BOTTLE in 1 BOX / 42.5 g in 1 BOTTLE 2026-01-19 — Active
85524-2602-04 85524-2602-4 1 BOTTLE in 1 BOX / 42.5 g in 1 BOTTLE Sample 2026-01-19 — Active
85524-2602-06 85524-2602-6 1 BOTTLE in 1 BOX / 42.5 g in 1 BOTTLE Sample 2026-01-19 — Active

Pack size FAQ

What quantity is in this package?
This package contains 1 bottle — 1 bottle in 1 box / 42.5 g in 1 bottle.
How does this package differ from NDC 85524-2602-04?
Both are Hemorrhoid and Fissure Glycerin 6%,Lidocaine 4%,Ectoin 0.12% .0012 g/g; .04 g/g; .06 g/g Ointment — the drug itself is identical. This page's package is the 1 bottle one, while NDC 85524-2602-04 is the 1 bottle package.
What NDC number is used to bill for this package of Hemorrhoid and Fissure Glycerin 6%,Lidocaine 4%,Ectoin 0.12% .0012 g/g; .04 g/g; .06 g/g Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Hemorrhoid and Fissure .0012 g/g; .04 g/g; .06 g/gthis 85524-2602-02 FlexiGo 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jan 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII TR046Y3K1G
    A liquid alcohol derived from petroleum or plant sources. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
  • UNII 3XUS85K0RA
    Butylene glycol is a clear liquid derived from petroleum or plants that acts as a humectant, solvent, and preservative booster in medicines. It helps keep formulations stable, dissolve active ingredients, and maintain moisture in topical products.
  • UNII E4F12ROE70
    A refined mineral oil derived from crude petroleum containing 13 to 14 carbon chains. It acts as a solvent, emollient, and carrier in topical formulations to help dissolve active ingredients and improve product texture and spreadability.
  • UNII 0A5MM307FC
    A synthetic polymer that absorbs water and forms a thick, gel-like substance. In medicines, it works as a thickener and stabilizer to improve texture and help ingredients stay mixed together in creams, gels, and lotions.
  • UNII I670DAL4SZ
    A preservative that fights bacteria and fungi. It keeps medicines and topical products stable and safe from microbial contamination during storage and use.
  • UNII Z525CBK9PG
    Acid Red 18 is a synthetic red dye used as a colorant in medicines. It gives tablets, capsules, and liquids their red or pink color so products are visually identifiable.
  • UNII I753WB2F1M
    FD&C Yellow No. 5 is a synthetic yellow colorant approved by the FDA. It is added to medicines to make pills, tablets, or liquids visually distinct and easier to identify.
  • UNII 2865993309
    Ethylhexyl palmitate is an oily chemical made from palm oil and alcohol. It acts as an emollient and skin-conditioning agent in topical medicines, helping the product spread smoothly and keeping skin soft.
  • UNII 230OU9XXE4
    A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
  • UNII 0RE8K4LNJS
    Isopropyl myristate is an oily liquid made from coconut or palm oil. It's used in medicines as an emollient and penetration enhancer to help the medicine absorb through skin or improve spreadability in topical products.
  • UNII Z95S6G8201
    A synthetic surfactant derived from lauryl alcohol and ethylene oxide. It helps dissolve and mix oily and watery ingredients in liquid formulations, and may improve how the medicine spreads or is absorbed.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII WV9CM0O67Z
    Panthenol is a humectant and skin-conditioning agent derived from pantothenic acid. It's added to medicines to help retain moisture and soothe skin irritation.
  • UNII YD01N1999R
    A waxy substance made from polyethylene glycol and stearic acid. It helps mix oil and water-based ingredients together and serves as an emulsifier and solubilizer in liquid and semi-solid medicines.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII CAL22UVI4M
    A synthetic emulsifier derived from sorbitol and fatty acids. It helps mix oil and water-based ingredients together and improves the texture and stability of the medicine.
  • UNII NVZ4I0H58X
    A waxy substance made from sorbitol and stearic acid. It acts as an emulsifier and stabilizer, helping keep oil and water mixed together and preventing separation in the medicine.
  • UNII B8WCK70T7I
    Trehalose is a natural sugar made from two glucose molecules linked together. It's used in medicines as a filler to add bulk, a sweetener for taste, and a stabilizer to help keep active ingredients effective during storage.
  • UNII 9O3K93S3TK
    Trolamine is an alkaline compound used as a pH buffer and emulsifier in medicines. It helps neutralize acids, stabilize formulations, and enable mixing of oil and water-based ingredients.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

20 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerFlexiGo Inc
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code85524
First marketedJan 2026
Product typeHuman Otc Drug
Portfolio13 products on file

More NDCs from FlexiGo Inc labeler code 85524

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 12 words ▾

INDICATIONS & USAGE SECTION INDICATIONS & USAGE SECTION INDICATIONS & USAGE SECTION

⏱️ Dosage and Administration 12 words ▾

DOSAGE & ADMINISTRATION SECTION DOSAGE & ADMINISTRATION SECTION DOSAGE & ADMINISTRATION SECTION

⚠️ Warnings 3 words ▾

WARNINGS WARNINGS WARNINGS

📦 Storage and Handling 12 words ▾

STORAGE AND HANDLING SECTION STORAGE AND HANDLING SECTION STORAGE AND HANDLING SECTION

🧪 Active Ingredient 6 words ▾

OTC-Active Ingredient OTC-Active Ingredient OTC-Active Ingredient

🧪 Inactive Ingredients 9 words ▾

Inactive ingredient section Inactive ingredient section Inactive ingredient section

🎯 Purpose 6 words ▾

OTC-PURPOSE SECTION OTC-PURPOSE SECTION OTC-PURPOSE SECTION

📄 Do Not Use 12 words ▾

OTC-DO NOT USE SECTION OTC-DO NOT USE SECTION OTC-DO NOT USE SECTION

📄 When Using This Product 3 words ▾

OTC-WHEN USING SECTION

📄 Stop Use and Ask a Doctor If 9 words ▾

OTC-STOP USE SECTION OTC-WHEN USING SECTION OTC-WHEN USING SECTION

📄 Keep Out of Reach of Children 14 words ▾

OTC-KEEP OUT OF REACH OF CHILDREN SECTION OTC-KEEP OUT OF REACH OF CHILDREN SECTION

📄 Package Label / Principal Display Panel 13 words ▾

PACKAGE LAVEL PRINCIPAL DISPLAY PANEL package label.PRINCIPAL DISPLAY PANEL package label.PRINCIPAL DISPLAY PANEL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by FlexiGo Inc. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 1 bottle (85524-2602-04), 1 bottle (85524-2602-06). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
FlexiGo Inc is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 85524-2601-01 · FlexiGo 85524-2605-02 · FlexiGo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.